NFKB1 and polycystic ovary syndrome: A previous study showed that S100A9 could increase the production of inflammatory cytokines and disturb steroidogenesis via activating nuclear factor kappa B (NF‐κB) signaling pathway in PCOS (Li et al., 2020).